Free Trial

Propanc Biopharma (PPCB) Short Interest Ratio & Short Volume

Propanc Biopharma logo
$4.25 +0.10 (+2.41%)
As of 07/3/2025 12:58 PM Eastern

Propanc Biopharma Short Interest Data

Propanc Biopharma (PPCB) has a short interest of 400 shares, representing 2.11% of the float (the number of shares available for trading by the public). This marks a ∞ increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 1,853 shares to cover all short positions.

Current Short Interest
400 shares
Previous Short Interest
0 shares
Change Vs. Previous Month
+∞
Dollar Volume Sold Short
$3.20 thousand
Short Interest Ratio
0.2 Days to Cover
Last Record Date
June 15, 2025
Outstanding Shares
20,000 shares
Short Percent of Float
2.11%
Today's Trading Volume
2,353 shares
Average Trading Volume
1,853 shares
Today's Volume Vs. Average
127%
Short Selling Propanc Biopharma?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Propanc Biopharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PPCB Short Interest Over Time

PPCB Days to Cover Over Time

PPCB Percentage of Float Shorted Over Time

Propanc Biopharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/2025400 shares $3.20 thousand No Change2.1%0.2 $8.00
5/15/2025100 shares $280.00 No Change0.0%0 $2.80
4/15/2025200 shares $979.12 No Change0.0%0.1 $4.90
3/31/2025200 shares $1.10 thousand No Change0.0%0.3 $5.50
3/15/2025200 shares $1.35 thousand +100.0%0.0%0.5 $6.75
2/28/2025100 shares $675.00 No Change0.0%0.1 $6.75
1/15/202532,200 shares $9.66 No ChangeN/A0 $0.00
10/31/202492,900 shares $27.87 No ChangeN/A0 $0.00
9/30/20241,578,600 shares $473.58 -16.2%N/A0.1 $0.00
9/15/20241,884,500 shares $753.80 +21.6%N/A0.3 $0.00
8/31/20241,550,100 shares $620.04 -46.4%N/A0.1 $0.00
8/15/20242,893,800 shares $1.16 thousand +1,784.0%N/A0 $0.00
7/31/2024153,600 shares $122.88 No ChangeN/A0 $0.00
6/30/202431,500 shares $39.38 -57.2%N/A0 $0.00
6/15/202473,600 shares $117.76 No ChangeN/A0 $0.00
5/15/202477,600 shares $54.32 +9.8%N/A0 $0.00
4/30/202470,700 shares $70.70 No ChangeN/A0 $0.00
3/31/20246,200 shares $19.84 No ChangeN/A0 $0.00
2/29/2024127,100 shares $432.14 +355.6%N/A0 $0.00
2/15/202427,900 shares $131.13 +39.5%N/A0 $0.00
1/15/202412,000 shares $120.00 +11,900.0%N/A0 $0.01
12/31/2023100 shares $1.20 -99.8%N/A0 $0.01
12/15/202359,300 shares $646.37 +352.7%N/A0 $0.01
11/30/202313,100 shares $111.35 +23.6%N/A0 $0.01
11/15/202310,600 shares $140.98 -74.9%N/A0 $0.01
10/31/202342,200 shares $481.08 +20.6%N/A0.1 $0.01
10/15/202335,000 shares $560.00 +18.2%N/A0 $0.02
9/30/202329,600 shares $722.24 +179.3%N/A0.1 $0.02
9/15/202310,600 shares $318.00 -64.7%N/A0 $0.03
8/31/202330,000 shares $1.65 thousand No ChangeN/A0 $0.05
7/31/202334,000 shares $2.76 thousand -5.0%N/A0 $0.08
7/15/202335,800 shares $3.38 thousand +21.8%N/A0 $0.09
6/30/202329,400 shares $3.97 thousand No ChangeN/A0 $0.14
5/15/2023310,100 shares $62.02 thousand +310,000.0%N/A0 $0.20
4/30/2023100 shares $0.03 -99.5%N/A0 $0.00
4/15/202318,100 shares $5.43 -90.4%N/A0 $0.00
3/31/2023188,600 shares $94.30 +887.4%N/A0 $0.00
3/15/202319,100 shares $11.46 -39.2%N/A0 $0.00
2/28/202331,400 shares $21.98 -7.9%N/A0 $0.00
2/15/202334,100 shares $10.23 -76.3%N/A0 $0.00
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)

Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?

Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.
1/31/2023144,000 shares $57.60 -28.0%N/A0 $0.00
1/15/2023200,100 shares $100.05 +200,000.0%N/A0 $0.00
12/30/2022100 shares $0.06 -99.8%N/A0 $0.00
12/15/202255,100 shares $33.06 -90.3%N/A0 $0.00
11/30/2022565,200 shares $395.64 +1,025.9%N/A0 $0.00
11/15/202250,200 shares $40.16 -49.9%N/A0 $0.00
10/31/2022100,200 shares $100.20 +57.8%N/A0 $0.00
10/15/202263,500 shares $76.20 -30.6%N/A0 $0.00
9/30/202291,500 shares $109.80 +45,650.0%N/A0 $0.00
9/15/2022200 shares $0.34 -99.3%N/A0 $0.00
8/31/202228,500 shares $54.15 -78.2%N/A0 $0.00
8/15/2022130,800 shares $300.84 +8.0%N/A0 $0.00
7/31/2022121,100 shares $399.63 -47.4%N/A0 $0.00
7/15/2022230,000 shares $575.00 +37.6%N/A0 $0.00
6/30/2022167,200 shares $618.64 +113.3%N/A0 $0.00
6/15/202278,400 shares $227.36 +27.7%N/A0 $0.00
5/31/202261,400 shares $466.64 +1,103.9%N/A0 $0.01
5/15/20225,100 shares $42.02 -70.5%N/A0 $0.01
4/30/202217,300 shares $193.76 -94.8%N/A0 $0.01
4/15/2022331,900 shares $3.95 thousand +824.5%N/A0.1 $0.01
3/31/202235,900 shares $560.04 +32.0%N/A0 $0.02
3/15/202227,200 shares $367.20 -3.9%N/A0 $0.01
2/28/202228,300 shares $478.41 No ChangeN/A0 $0.02
1/31/202220,400 shares $393.72 No ChangeN/A0 $0.02
12/31/20213,400 shares $149.60 -83.2%N/A0 $0.04
12/15/202120,200 shares $466.62 No ChangeN/A0 $0.02
11/15/20213,800 shares $114.00 +11.8%N/A0 $0.03
10/29/20213,400 shares $99.28 +209.1%N/A0 $0.03
10/15/20211,100 shares $30.58 -94.8%N/A0 $0.03
9/30/202121,100 shares $548.60 No ChangeN/A0 $0.03
8/31/202125,000 shares $1.18 thousand No ChangeN/A0 $0.05
7/30/202116,600 shares $595.94 +5.7%N/A0 $0.04
7/15/202115,700 shares $703.36 +17.2%N/A0 $0.04
6/30/202113,400 shares $692.78 -41.7%N/A0 $0.05
6/15/202123,000 shares $1.82 thousand -60.8%N/A0 $0.08
5/28/202158,600 shares $4.69 thousand +4,783.3%N/A0.1 $0.08
5/14/20211,200 shares $156.00 -75.0%N/A0 $0.13
4/30/20214,800 shares $1.03 thousand +269.2%N/A0.1 $0.22
4/15/20211,300 shares $273.00 -74.0%N/A0 $0.21
3/31/20215,000 shares $1.25 thousand -27.5%N/A0 $0.25
3/15/20216,900 shares $3.11 thousand -60.1%N/A0.1 $0.45
2/26/202117,300 shares $5.02 thousand -8.0%N/A0.1 $0.29
2/12/202118,800 shares $8.08 thousand +2,250.0%N/A0 $0.43
1/29/2021800 shares $332.08 -75.8%N/A0 $0.42
12/31/20202,000 shares $620.00 No ChangeN/A0 $0.31
10/30/2020100 shares $0.17 No ChangeN/A0 $0.00
9/30/202084,100 shares $159.79 +188.0%N/A0 $0.00
9/15/202029,200 shares $52.56 +2,820.0%N/A0 $0.00
8/31/20201,000 shares $2.40 No ChangeN/A0 $0.00
7/15/202012,900 shares $34.83 No ChangeN/A0 $0.00
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)

Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?

Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.

PPCB Short Interest - Frequently Asked Questions

What is Propanc Biopharma's current short interest?

Short interest is the volume of Propanc Biopharma shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 400 shares of PPCB short. 2.11% of Propanc Biopharma's shares are currently sold short. Learn More on Propanc Biopharma's current short interest.

What is a good short interest percentage for Propanc Biopharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.11% of Propanc Biopharma's floating shares are currently sold short.

Is Propanc Biopharma's short interest increasing or decreasing?

Propanc Biopharma saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 400 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Propanc Biopharma's short interest compare to its competitors?

2.11% of Propanc Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Propanc Biopharma: Kiromic BioPharma, Inc. (0.01%), Smart for Life, Inc. (0.01%), TC Biopharm (Holdings) Plc (176.43%), Vincerx Pharma, Inc. (0.05%), Bon Natural Life Limited (97.97%), GlobeStar Therapeutics Corporation (0.00%), Neptune Wellness Solutions Inc. (1.19%), Optec International, Inc. (0.00%), NovAccess Global Inc. (0.00%), Scopus BioPharma Inc. (0.03%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks.

What does it mean to sell short Propanc Biopharma stock?

Short selling PPCB is an investing strategy that aims to generate trading profit from Propanc Biopharma as its price is falling. PPCB shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Propanc Biopharma?

A short squeeze for Propanc Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PPCB, which in turn drives the price of the stock up even further.

How often is Propanc Biopharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PPCB, twice per month. The most recent reporting period available is June, 15 2025.




This page (OTCMKTS:PPCB) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners